Mondays at 3:00 p.m. 
3535 Market Street,
5th Floor, Conference Room 5102

Winter 2019

February 10, 2020
Jill Rabinowitz, Ph.D.
Assistant Research Scientist
Johns Hopkins Bloomberg School of Public Health
“Environmental and Polygenic Influences on Drug Use and Related Psychopathology in Admixed Populations”


March 30, 2020
Emma Johnson, Ph.D.
Postdoctoral Research Associate in the Department of Psychiatry
Washington University School of Medicine in St. Louis
“Using a Variety of Genome-wide Methods to Investigate the Shared Genetic Underpinnings of Alcohol Use Disorder and Schizophrenia”

(more to be announced)


Past Seminars

Fall 2019

October 14, 2019
Philipp Koellinger, Ph.D.
Full Professor at the School of Business and Economics
Vrije Universiteit Amsterdam
"Risky Behaviors and their Links with Health: New Insights from Statistically Well-Powered Genetic and Neuroscientific Studies"

November 11, 2019 
Special Seminar—The 2019 Charles O’Brien Lecture

Jon-Kar Zubieta, M.D., Ph.D.
Chairman of the Department of Psychiatry and Psychiatrist-in-Chief
University of Utah Neuropsychiatric Institute
“Endogenous Opioids: At the Interface of Emotions, Pain and the Addictions”

November 18, 2019
Lorenzo Leggio, M.D. Ph.D., M.Sc.
Chief of the Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology (a NIAAA and NIDA joint laboratory)
"Traversing the Gut-Brain Axis: Translation to Addiction Medicine"

December 16, 2019
Rachel Kember, Ph.D.
Research Associate in the Department of Genetics
Perelman School of Medicine at the University of Pennsylvania
“Phenotypic Associations of Genetic Liability for Opioid Use Disorder in the Penn Medicine Biobank”

Summer 2019

August 22, 2019 (Thursday at 3:00 p.m.)
Special Seminar—Note Different Day

Christopher Rentsch, Ph.D., MPH
London School of Hygiene and Tropical Medicine
“Polypharmacy and Alcohol Interactions on Patient Outcomes”

Spring 2019

April 15, 2019
Emily A. Largent, JD, Ph.D. and Holly Fernandez Lynch, JD, MBE,
Department of Medical Ethics and Health Policy
Perelman School of Medicine at the University of Pennsylvania
“Undue Inducement and Inducing Deception: Offers of Payment for Research Participation”

April 17, 2019 (Wednesday at 4:30 p.m.)
Special Seminar—Note Different Timing

Corinde Wiers, Ph.D.,
Laboratory of Neuroimaging
Research Fellow at the National Institute on Alcohol Abuse and Alcoholism
“How PET Imaging can Inform Interventions for Alcohol Use Disorder”

April 22, 2019
Ann Marie Hoyt-Brennan, MSN, RN
Simulation Education Specialist
Director, Helene Fuld Pavilion for Innovative Learning and Simulation
University of Pennsylvania, School of Nursing
“Public Health Meets Simulation: Addressing the Opioid Epidemic Through the Use of Virtual Reality”

Winter 2019

January 28, 2019
Igor Elman, Ph.D., MPH
Cooper University, Chairman of the Department of Psychiatry
"Reward Deficiency and Anti-Reward Processes in Stress-related and Addictive Disorders"

February 11, 2019
Jena Tronieri, Ph.D. 
Assistant Professor of Psychology in the Department of Psychiatry
Perelman School of Medicine at the University of Pennsylvania
Director of Clinical Services at the Center for Weight and Eating Disorders
"Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial"

February 18, 2019
Alicia Allen, Ph.D., MPH
University of Arizona, Assistant Professor
The Department of Family and Community Medicine and Public Health at the College of Medicine
"A Pack of Pills and a Puff of Smoke: Could Hormonal Contraceptives be Influencing Cigarette Smoking?"

February 26, 2019 (Tuesday at 4:00 p.m.)
Special Seminar—Note Different Timing

Mariya Cherkasova, Ph.D.
University of British Columbia
Pacific Parkinson's Research Centre
"Reward Cues and Motivated Behavior: Decision Making, Dopamine and Addiction"

March 18, 2019
Laura Almasy, Ph.D.
University of Pennsylvania, Professor of Genetics
Department of Biomedical and Health Informatics
Director of Biostatistics, Lifespan Brain Institute
"Beyond Cases and Controls: Quantitative and Multifaceted Phenotypes in Gene Discovery for Complex Traits"

Back to Top

Fall 2018

September 17, 2018
Terry Horton, MD
Chief of Christiana Care's Division of Addiction Medicine and Medical Director for Project Engage
"Hospital as a Reachable Moment"

September 24, 2018
Leslie Morrow, PhD
University of North Carolina, Professor in the Department of Psychiatry at the Bowles Alcohol Research Center
"Novel Mechanism of Neurosteroid Actions: Relevance to Neuropsychiatric Disease"

October 8, 2018
Gideon Nave, Ph.D.
University of Pennsylvania, Assistant Professor of Marketing at the Wharton School
"Evaluating the Replicability of Social Science Experiments in Nature and Science between 2010 and 2015"

October 15, 2018
Jacob Dubroff, MD Ph.D.
Assistant Professor of Radiology
Division of Nuclear Medicine & Clinical Molecular Imaging
Perelman School of Medicine at the University of Pennsylvania
"Addiction PET Imaging at Penn: nAChR Imaging and Beyond"

October 22, 2018
Irina Esterlis, Ph.D.
Yale University, Associate Professor and Director of the Molecular Imaging Program 
"Where Does Glutamate Fit in the Neurobiology of PTSD? Lessons from Animal Models, Human Imaging Studies, and Clinical Trials"

November 19, 2018
David Metzger, Ph.D.
Research Professor and Director of the HIV Prevention Research Division 
Perelman School of Medicine at the University of Pennsylvania
“Rapid Initiation of Buprenorphine/Naloxone to Optimize MAT in Philadelphia”

November 26, 2018 (CANCELLED)
Rebecca Ashare, Ph.D.
Assistant Professor, Perelman School of Medicine at the University of Pennsylvania
Center for Interdisciplinary Research on Nicotine Addiction
Senior Fellow, Center for Public Health Initiatives
“Treating Tobacco Use among People Living with HIV”

December 3, 2018
Jeanmarie Perrone, MD
Director, Division of Medical Toxicology, Department of Emergency Medicine
Professor of Emergency Medicine at the Hospital of the University of Pennsylvania 
"Research Initiatives in the Opioid Crisis to Inform Evidence-Based Change"

December 17, 2018
Laura Almasy, Ph.D.
University of Pennsylvania, Professor of Genetics
Department of Biomedical and Health Informatics
Director of Biostatistics, Lifespan Brain Institute
"Beyond Cases and Controls: Quantitative and Multifaceted Phenotypes in Gene Discovery for Complex Traits"

Back to Top

Spring 2018

March 26, 2018
Henry Kranzler, MD
University of Pennsylvania, Director of Center for Studies of Addiction
The Million Veteran Program

April 9, 2018
Rachel Kember, PhD
University of Pennsylvania, Department of Genetics
Differences between AUDIT-C and AUD phenotypes revealed by genome-wide analysis

April 23, 2018
Katie Witzkiewicz, PhD
University of New Mexico, Professor of Department of Psychology, Center on Alcoholism, Substance Abuse & Addictions
Alcohol use disorder from public health, harm reduction, and health promotion perspectives

Back to Top

Winter 2018

January 29, 2018
Kyle Kampman, MD
University of Pennsylvania, Center for Studies of Addiction, Professor of Department of Psychiatry
New formulations of buprenorphine for the treatment of opioid use disorder

February 12, 2018
Elissa Kranzler, MSEd, MA
University of Pennsylvania, Doctoral Candidate at the Annenberg School of Communication
Examining the Psychological Processes Underlying Effects of "The Real Cost" Youth-targeted Anti-Smoking Campaign

February 26, 2018
Jacqui Barker, PhD
Drexel University School of Medicine, Assistant Professor Department of Pharmacology & Physiology
Dissecting the neural circuits that arbitrate between habitual and goal-directed response strategies

March 12, 2018
Dorian Lamis, PhD
Emory University School of Medicine, Assistant Professor of Psychiatry & Behavioral Sciences
Enhancing patients' life meaning and purpose in the treatment of depression and suicidal behaviors

Back to Top

Fall 2017 

September 18, 2017
Henry Kranzler, MD
University of Pennsylvania, Director of Center for Studies of Addiction
Predatory Publishing Threatens Science

October 2, 2017
Daniel Fridberg, PhD
University of Chicago, Department of Psychiatry and Behavioral Neuroscience
Using smartphones to assess alcohol responses in young adults

October 23, 2017
Reagan Wetherill, PhD
University of Pennsylvania, CSA Faculty
Addiction as a Brain Disease

November 6, 2017
Kelly Cosgrove, PhD
Yale University, Associate Professor of Psychiatry, Radiology, and Biomedical Imaging of Neuroscience
Imaging sex differences in tobacco smoking with PET

November 27, 2017
Ali Ely, PhD
Psychologist at the Center for Heart and Vascular Health, Value Institute Scholars Program, Behavioral Health Service Line, Christiana Care Health System
Novel findings in the neurobiology of obesity in smoking

December 11, 2017
 Natalia A. Quijano Cardé, PhD Candidate
University of Pennsylvania, Department of Systems Pharmacology and Translational Therapeutics
Selective GluK1-containing Kainate Receptor Blockade Modulates Alcohol Self-Administration in Mice
Back to Top

Spring 2017 

January 23, 2017
Anne M. Teitelman, PhD, FNP-BC, FAANP, FAAN
University of Pennsylvania, School of Nursing
Using brain imaging to augment our understanding of HIV risk behaviors in young adult women

January 30, 2017
Deborah S. Hasin, PhD
Columbia University, Department of Psychiatry & Epidemiology
Marijuana use and cannabis use disorders in the US – changing times

March 27, 2017
Peggy Compton, RN, PhD, FAAN
Georgetown University, School of Nursing and Health Studies
Opioid-Induced Hyperalgesia (OIH): Is it Clinically Relevant?

April 3, 2017
Marisa Silveri, PhD
Harvard Medical School, Department of Psychiatry
Developmental Profiles of Neurochemistry: Adolescence, Emerging Adulthood and Implications for Risky Drinking

April 10, 2017
Cécile Denis, PhD
University of Pennsylvania, Department of Psychiatry
Common Assessment for Substance-Related and Addictive Disorders: Utility for Clinic and Research

April 17, 2017
Michael Lowe, PhD and Samantha Winter, PhD Candidate
Drexel University, Department of Psychology
Weight Gain, Weight Loss and Body Mass: Is the Noise a Signal?

April 24, 2017
Ariana Chao, PhD, RN, CRNP
University of Pennsylvania, Department of Psychiatry
Binge eating disorder and addictive-like eating: Implications for obesity treatment

May 1, 2017
Tracy Bale, PhD
University of Pennsylvania, Neuroscience Center SOVM
Parental stress and epigenetic programming of offspring neurodevelopment Dr. Franklin to introduce

May 8, 2017
Bruce Herdman, PhD, MBA
Chief of Medical Operations, Philadelphia Prison System
Medical and Addiction Treatment Services in the Philadelphia Prison System

May 15, 2017
Adam Bisaga, MD
Columbia University Medical Center, Department of Psychiatry
Extended-release naltrexone for Opioid Use Disorder: Improving Methods of Treatment Initiation
Back to Top

Fall 2016

September 19
Salina Samion, PhD
CNB Psychological Servies Unit
Central Narcotics Bureau, Singapore
Substance Use Disorders and Their Treatment in Singapore

September 26, 2016
Kevin Lynch, PhD
University of Pennsylvania, Department of Psychiatry
Analyses of heavy drinking in a topiramate study

October 3, 2016
Zhenhao Shi, PhD
University of Pennsylvania, Department of Psychiatry
Extended-release naltrexone specifically blunts the mesocorticolimbic response to opioid-related images in opioid-dependent patients

October 10, 2016
Douglas Wiebe, PhD
University of Pennsylvania, Department of Clinical Epidemiology and Biostatistics 
Ignition Interlock Laws and Alcohol-Involved Crash Deaths

October 17, 2016
Dan Polsky, PhD
University of Pennsylvania, Department of Health Care Management
Cost-Effectiveness of Depot Naltrexone to Prevent Relapse Among Criminal-Justice-Involved Persons with a History of Opioid Use Disorder

October 24, 2016
Kenzie L. Preston, PhD
NIH National Institute on Drug Abuse, Clinical Pharmacology and Therapeutics Research Branch
Substance Abuse Research with Mobile Technology

October 31, 2016
Charles O’Brien, MD
University of Pennsylvania, Department of Psychiatry
Relapse prevention using depot naltrexone for parolees

November 7, 2016
Christos Davatzikos, PhD
University of Pennsylvania, Department of Radiology
Deriving personalized neuroimaging signatures using machine learning in the presence of heterogeneity: applications to brain aging, Alzheimer's Disease, and schizophrenia

November 14, 2016
Mohit Prajapati, MSc(Eng), MBA and Sam Frons
Addicaid: An application for personalized addiction treatment

November 21, 2016
Daniel Weintraub, MD
University of Pennsylvania, Department of Psychiatry
Impulse Control Disorders in Parkinson's Disease

November 28, 2016
Falk Lohoff, MD
National Institute on Alcohol Abuse and Alcoholism, Chief of Section on Clinical Genomics and Experimental Therapeutics
Epigenetics of Alcohol Use Disorder

December 5, 2016
Ilana Pinsky, PhD
The National Center on Addiction and Substance Abuse
`Cracolandia`, an open drug scene in Brazil: treatment opportunities and challenges

December 12, 2016
Robert Mach, PhD
University of Pennsylvania, Department of Radiology
Development of Dopamine D2 and D3 Selective Radiotracers for PET
Back to Top

Spring 2016

January 11
Francis Levin, MD
Columbia University Medical Center, Department of Psychiatry
ADHD in Substance Abuse

January 25
Martin Cheatle, PhD
University of Pennsylvania, Department of Psychiatry 
Phenotypic and genotypic characteristics of opioid use disorder in patients with chronic non cancer pain

February 1
Charles Branas, PhD
University of Pennsylvania, Department of Biostatistics and Epidemiology 
Changing Places to Improve Health 

February 8
Jennifer Prah Ruger, PhD, MSc, MA, MSL
University of Pennsylvania, Department of Medical Ethics & Health Policy 
Micro costing: studies, systematic review and checklist development

February 29
Walter Kraft, MD, MS, FACP
Thomas Jefferson University, Clinical Pharmacology
Novel Therapies for Neonatal Abstinence Syndrome

March 7
Rick C. Crist, III, PhD
University of Pennsylvania, Department of Psychiatry
The Pharmacogenetics of Opioid Dependence Treatment

March 14
Dennis Hand, PhD 
Thomas Jefferson University
Strategies for Preventing Unintended Pregnancies Among Women in Substance Abuse Treatment

March 21
Raye Litten, PhD 
National Institutes of Health, NIAAA 
A Vision for the Next Decade to Advance Medications Development to Treat Alcohol Use Disorder

March 28
J. Cobb Scott, PhD
University of Pennsylvania, Department of Neuropsychiatry
Cannabis and Cognitive Functioning - Findings from the Philadelphia Neurodevelopmental Cohort

April 4
John Cacciola, PhD
University of Pennsylvania, Department of Psychiatry
Performance Monitoring in Addiction Treatment

April 11
Lyle Ungar, PhD
University of Pennsylvania, Computer and Information Science 
Social Media Language Analysis for Health Behaviors

April 18
Dennis Durbin, MD, MSCE 
University of Pennsylvania/CHOP, Department of Pediatrics
Being Intentional about Work/Life Integration

May 2
John Farrar, MD 
University of Pennsylvania, Department of Epidemiology and Biostatistics
Brain Imaging in Pain and Addiction

May 9
Marlow Kee 
University of Pennsylvania, Executive Director of the Comptroller 
A comptroller’s-eye view of funds flow in the Perelman School of Medicine and the University of Pennsylvania

May 16
Marja Evenden, MD 
University of Pennsylvania, Department of Psychiatry
On GABA-A Receptor Ligands in Clinical Psychiatry

May 23
Robin Stevens, PhD, MPH 
University of Pennsylvania, School of Nursing
Social Media and Other Drugs: Sex and substance use among inner city youth

June 20
Bethany Raiff, PhD, BCBA-D
Rowan University, Department of Psychology 
Technology-based interventions for increasing healthy behavior 
Back to Top

Fall 2015

September 14
Diane Abatemarco, PhD, MSW
Research in Mindfulness Based Programs with Women Treated for Opioid Addiction Post-Partum & with Pregnant Women at Risk for Preterm Birth

September 21
Subhajit Chakravorty, MD
Alcohol and Sleep Continuity Distrubance: Newer Insights

October 5
Steven E. Lankenau, PhD
Health Conditions and Patterns of Marijuana Use among Young Adult Medical Marijuana Patients in Los Angeles

October 12
Teresea Franklin, PhD
Influence of Sex on Neural Processing Of Subliminal Cannabis Cues In Cannabis Use Disorder (CUD): Implications for Treatment Strategies

October 19
Craig A. Umscheid, MD, MSCE
Intro to Systematic Reviews and Meta-analyses

October 26
Ulf  Muller, MD
A controlled funded study of DBS for alcoholism in Germany

November 2
David Thomas, MD
NIDA Current and Future Initiatives in Pain and Addiction

November 9
Peg Calder
FAR: Why, How, and What

November 16
Andrew Strasser, PhD
Applying Human Laboratory Research to FDA Regulation of Tobacco Products

November 23
Mehmet Sofouglu, MD, PhD
Role of Progesterone in Additive Disorders: Human Laboratory and Clinical Trial Findings

November 30
Deni Carise, PhD
Developing De Novo Substance Abuse Treatment Programs – Zoning, Stigma and other challenges

December 14
Hengyi Rao, PhD
Smoking to be normal: A multimodal neuroimaging study of nicotine abstinence

December 21
Janet Audrain, PhD
Using Behavioral Economics to Understand Smoking Uptake and Persistence
Back to Top

Spring 2015

February 2
Sara Ward, PhD
Cocaine, cannabinoids, and inflammation

February 9
David Metzger, PhD
Drug Treatment as HIV Prevention in Asia: from Harm reduction to Addiction Treatment

February 23
Hans Rollema, PhD
Varenicline (Chantix) a decade later: an update on pharmacology, efficacy, adverse events and other indication

March 2
Andrea King, PhD
If you build it, they will come: a longitudinal framework for alcohol challenge research in at-risk drinkers 
March 9
Julie Blendy, PhD
Stress, alcohol and the social mouse: Functional characterization of Oprm1 SNP

March 16
Robert Gross, MD, MSCE
Impact of Hazardous Ethanol Consumption on HIV Outcomes in Botswana

March 23
Emily Falk, PhD
Neural predictors of health behavior change

March 30
Alyse Thomas, PhD
Stress promotes alcohol consumption through excitatory GABA transmission in the VTA

April 6
Irwin Lucki, PhD
Repurposing Buprenorphine for Depression and Anxiety Disorders

April 27
Victor Hesselbrock, PhD

May 4
Erika Perez, PhD and Duncan Van Nest, BS
GluK1-containing Kainate Receptor Antagonists as Potential Pharmacotherapies for Alcohol and Cocaine Dependence

May 11
Paul Lanken, MD
Efficacy of an Online Educational Module plus Debriefing to Improve Attitudes and Communication Skills Related to Patients with Substance Use
Back to Top

Fall 2014

September 8
Dr. Robert Schnoll, PhD 
Improving Treatments for Nicotine Dependence

September 15
Dr. Yukiko Washio, PhD
Addressing Maternal Health Issues with a Comprehensive Approach

September 22
Dr. Brenda Curtis, PhD 
Using Marketing Techniques to Recruit and Retain Research Participants

September 29
Dr. Joseph Schacht, PhD 
Identification of Neural Targets for Pharmacological Treatment in Alcohol Use Disorders

October 6
Dr. Amy Hart, MD
Investigating the Genetic Influences on Substance Use Disorders Using a  Genome-Wide Approach

October 13
Dr. Reagan Wetherill, PhD 

October 20
Dr. Kimberly Kirby, PhD 
Progress Report from the Parents' Translational Research Center
October 27
Dr. John Dani, PhD
Dopaminergic Mechanisms Contributing to the Nicotine Addiction Process

November 3
Dr. David Festinger, PhD 
Delivering HIV Risk Reduction Services in Drug Court

November 10
Dr. Neil Epperson, MD 
What? You Give Progesterone to Men? The Role of Neurosteroids in Nicotine Dependence

November 17
Dr. Rebecca Ashare, PhD
From brain to behavior: The role of APOE ε4 genotype, a susceptibility allele for Alzheimer’s disease, in nicotine dependence

November 24
Dr. Kenneth Silverman, PhD 
Incentives & Health: The Application of Operant Conditioning in Health Promotion

December 1
Jeremy Mennis, PhD
Addiction and the Environment: Why Place Matters to Substance Abuse and Treatment

December 15
Dr. Kyle Kampman, MD
An Update on Topiramate for Cocaine Dependence

December 22
Dr. Heath Schmidt, PhD 

Back to Top